Qyuns Therapeutics (02509) Announces Next Day Disclosure Return and Share Repurchase Details

Bulletin Express01-30

Qyuns Therapeutics (02509) disclosed a share repurchase undertaken on 30 January 2026. According to the announcement, 91,200 shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 20.96 to HKD 21.9, with a total consideration of approximately HKD 1,957,252.32. These shares are classified as treasury shares, increasing the total treasury share count to 2,197,000 as of that day.

The total number of issued shares remains at 227,071,600, while the number of issued shares excluding treasury shares stands at 224,874,600. The repurchase is subject to a mandate approved on 20 June 2025, which authorizes up to 22,207,160 shares for repurchase. Under the mandate, there is a moratorium period restricting any new share issuance or sale or transfer of treasury shares until 1 March 2026, as per listing rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1154827312?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-30 21:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154827312","market":"hk","top_or_hot":-1,"title":"Qyuns Therapeutics (02509) Announces Next Day Disclosure Return and Share Repurchase Details","media":"Bulletin Express","content":"<p>Qyuns Therapeutics (02509) disclosed a share repurchase undertaken on 30 January 2026. According to the announcement, 91,200 shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 20.96 to HKD 21.9, with a total consideration of approximately HKD 1,957,252.32. These shares are classified as treasury shares, increasing the total treasury share count to 2,197,000 as of that day.</p>\n<p>The total number of issued shares remains at 227,071,600, while the number of issued shares excluding treasury shares stands at 224,874,600. The repurchase is subject to a mandate approved on 20 June 2025, which authorizes up to 22,207,160 shares for repurchase. Under the mandate, there is a moratorium period restricting any new share issuance or sale or transfer of treasury shares until 1 March 2026, as per listing rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qyuns Therapeutics (02509) Announces Next Day Disclosure Return and Share Repurchase Details</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQyuns Therapeutics (02509) Announces Next Day Disclosure Return and Share Repurchase Details\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-30 21:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Qyuns Therapeutics (02509) disclosed a share repurchase undertaken on 30 January 2026. According to the announcement, 91,200 shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 20.96 to HKD 21.9, with a total consideration of approximately HKD 1,957,252.32. These shares are classified as treasury shares, increasing the total treasury share count to 2,197,000 as of that day.</p>\n<p>The total number of issued shares remains at 227,071,600, while the number of issued shares excluding treasury shares stands at 224,874,600. The repurchase is subject to a mandate approved on 20 June 2025, which authorizes up to 22,207,160 shares for repurchase. Under the mandate, there is a moratorium period restricting any new share issuance or sale or transfer of treasury shares until 1 March 2026, as per listing rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"","article_id":"1154827312","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154827312","pubTimestamp":1769780562,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Qyuns Therapeutics (02509) disclosed a share repurchase undertaken on 30 January 2026. According to the announcement, 91,200 shares were repurchased on the Hong Kong Stock Exchange at prices ranging...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02509":"荃信生物-B"},"translate_title":"Qyuns Therapeutics(02509)公布翌日披露报表及股份购回详情","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1},"content_text":"Qyuns Therapeutics (02509) disclosed a share repurchase undertaken on 30 January 2026. According to the announcement, 91,200 shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 20.96 to HKD 21.9, with a total consideration of approximately HKD 1,957,252.32. These shares are classified as treasury shares, increasing the total treasury share count to 2,197,000 as of that day.\nThe total number of issued shares remains at 227,071,600, while the number of issued shares excluding treasury shares stands at 224,874,600. The repurchase is subject to a mandate approved on 20 June 2025, which authorizes up to 22,207,160 shares for repurchase. Under the mandate, there is a moratorium period restricting any new share issuance or sale or transfer of treasury shares until 1 March 2026, as per listing rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1154827312","isCrawlerRequest":true}